Filing Details

Accession Number:
0001127602-22-024970
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-11-04 16:48:22
Reporting Period:
2022-11-02
Accepted Time:
2022-11-04 16:48:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
97745 Thermo Fisher Scientific Inc. TMO Measuring & Controlling Devices, Nec (3829) 042209186
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1216055 N Marc Casper 168 Third Avenue
Waltham MA 02451
Chairman & Ceo Yes Yes No No
Transaction Summary
Sold: 11,800 shares Avg. Price: $500.06 Total Value: $5,900,693.80
Number of Shares After Transactions: 186,205 shares
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-11-02 10,000 $129.77 188,005 No 4 M Direct
Common Stock Disposition 2022-11-02 572 $490.92 187,433 No 4 S Direct
Common Stock Disposition 2022-11-02 200 $491.42 187,233 No 4 S Direct
Common Stock Disposition 2022-11-02 567 $493.09 186,666 No 4 S Direct
Common Stock Disposition 2022-11-02 300 $493.92 186,366 No 4 S Direct
Common Stock Disposition 2022-11-02 300 $495.16 186,066 No 4 S Direct
Common Stock Disposition 2022-11-02 200 $495.89 185,866 No 4 S Direct
Common Stock Disposition 2022-11-02 200 $498.60 185,666 No 4 S Direct
Common Stock Disposition 2022-11-02 300 $500.27 185,366 No 4 S Direct
Common Stock Disposition 2022-11-02 300 $501.75 185,066 No 4 S Direct
Common Stock Disposition 2022-11-02 893 $503.28 184,173 No 4 S Direct
Common Stock Disposition 2022-11-02 970 $504.06 183,203 No 4 S Direct
Common Stock Disposition 2022-11-02 700 $505.53 182,503 No 4 S Direct
Common Stock Disposition 2022-11-02 915 $506.62 181,588 No 4 S Direct
Common Stock Disposition 2022-11-02 1,000 $507.56 180,588 No 4 S Direct
Common Stock Disposition 2022-11-02 600 $508.54 179,988 No 4 S Direct
Common Stock Disposition 2022-11-02 900 $509.62 179,088 No 4 S Direct
Common Stock Disposition 2022-11-02 683 $510.53 178,405 No 4 S Direct
Common Stock Disposition 2022-11-02 200 $511.87 178,205 No 4 S Direct
Common Stock Disposition 2022-11-02 200 $512.60 178,005 No 4 S Direct
Common Stock Acquisiton 2022-11-03 10,000 $129.77 188,005 No 4 M Direct
Common Stock Disposition 2022-11-03 200 $477.27 187,805 No 4 S Direct
Common Stock Disposition 2022-11-03 100 $477.95 187,705 No 4 S Direct
Common Stock Disposition 2022-11-03 600 $480.20 187,105 No 4 S Direct
Common Stock Disposition 2022-11-03 900 $481.89 186,205 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2022-11-02 10,000 $0.00 10,000 $129.77
Common Stock Stock Option (Right to Buy) Disposition 2022-11-03 10,000 $0.00 10,000 $129.77
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
28,100 2023-02-24 No 4 M Direct
18,100 2023-02-24 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 26, 2021.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $490.80 to $491.04, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5), (6), (7), (8), (9), (10), (11), (12), (13), (14), (15), (16), (17), (18), (19), (20), (21), (22), and (23) to this Form 4.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $491.15 to $491.69, inclusive.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $492.78 to $493.46, inclusive.
  5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $493.84 to $494.07, inclusive.
  6. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $494.88 to $495.53, inclusive.
  7. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $495.88 to $495.89, inclusive.
  8. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $498.49 to $498.71, inclusive.
  9. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $499.86 to $500.85, inclusive.
  10. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $501.23 to $502.19, inclusive.
  11. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $502.74 to $503.70, inclusive.
  12. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $503.79 to $504.56, inclusive.
  13. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $505.02 to $505.67, inclusive.
  14. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $506.08 to $507.03, inclusive.
  15. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $507.15 to $507.94, inclusive.
  16. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $508.16 to $509.12, inclusive.
  17. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $509.18 to $510.06, inclusive.
  18. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $510.18 to $511.16, inclusive.
  19. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $511.53 to $512.20, inclusive.
  20. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $512.55 to $512.65, inclusive.
  21. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $476.81 to $477.73, inclusive.
  22. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $479.77 to $480.39, inclusive.
  23. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $481.44 to $482.35, inclusive.
  24. The option vested in four equal installments on February 24, 2017, 2018, 2019, and 2020.